UK-based drugmaker Mylan has received a boost in its fight to stave off a takeover bid from Israeli pharma company Teva. Billionaire investor John Paulson has put his weight behind the company by boosting his stake in it through his fund. Paulson & Co’s 7-million-share purchase put its stake in the pharma company at 22 million shares, worth a combined $1.6 billion. Of course, Mylan is guilty of having made three unsuccessful attempts to acquire Irish OTC drugmaker Perrigo. While Mylan is not looking forward to its just desserts in the Teva case, its fight has definitely received a fillip from Paulson.
Billionaire investor John Paulson comes to the rescue of the drugmaker Mylan with a 7-million-share purchase
Summer wine and salad
Kishore Singh - January 19, 2015
A double topping for growth
Meghna Maiti - January 15, 2015
Scriptures for success
Kripa Mahalingam - January 27, 2015
The million-dollar question: Is investing a game of luck or skill?
Shankar Sharma - May 04, 2021
Decoupage goes digital
Kishore Singh - January 27, 2015